Gilead Sciences (NASDAQ:GILD)

biotech word cloud

Short Sellers Grow More Aggressive on Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
Hepatitis Virus

Gilead Scores Another Hepatitis FDA Approval

The biotech industry had enjoyed years of growth, but the past year was tarnished on the political election rhetoric about drug pricing. If one company had been at the center of criticism, ...
Read Full Story »
biotech word cloud

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
automatic inspection machine

How Analysts View Value and Opportunity in Gilead After Earnings

If you just looked at formal Buy and Sell ratings from Wall Street analysts, you might assume that everything is still fine and hopeful for Gilead Sciences Inc. (NASDAQ: GILD). ...
Read Full Story »
Prescription Drugs, Pills

Has Gilead Finally Bottomed?

Gilead Sciences Inc. (NASDAQ: GILD) released third-quarter earnings report after markets closed on Tuesday. Despite negative news coming out on Tuesday with former presidential candidate Bernie Sanders taking a shot ...
Read Full Story »
biotech word cloud

What to Expect From Gilead Earnings

Gilead Sciences Inc. (NASDAQ: GILD) is scheduled to release its third-quarter financial results after the markets close on Tuesday. The health care sector has been under fire recently, and some ...
Read Full Story »
ThinkstockPhotos-475180302

8 Top Earnings for the Week Ahead

24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. Earnings season is in full swing, when most major companies ...
Read Full Story »
biotech word cloud

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, October 14. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
Pills and tablets

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

It is no secret that the health care system in America needs help. Treatment costs have gone through the roof over the past two decades, and there is an ongoing ...
Read Full Story »
graph

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

It’s a tired refrain, as we have written about it for over a year, but the beating that the health care sector has taken, especially the biotechs, may be providing ...
Read Full Story »
Stock Price

Ericsson, Nokia Stumble into Thursday’s 52-Week Low Club

October 13, 2016: Here are four stocks trading with relatively heavy volume among 80 equities making new 52-week lows in Thursday's session. On the NYSE, decliners led advancers by 2 ...
Read Full Story »
Stock Price

Ericsson, Gilead Tumble Into Wednesday’s 52-Week Low Club

October 12, 2016: Here are four stocks trading with relatively heavy volume among 52 equities making new 52-week lows in Wednesday's session. On the NYSE, advancers led decliners by a ...
Read Full Story »
biotech word cloud

Short Sellers Have Mixed Views on Major Biotechs

The short interest data are out for the most recent settlement date, September 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
Stock Price

Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club

October 11, 2016: Here are four stocks trading with relatively heavy volume among 69 equities making new 52-week lows in Tuesday's session. On the NYSE, decliners led advancers by about ...
Read Full Story »
Stock Price

Gilead, Mylan Return to Friday’s 52-Week Low Club

October 7, 2016: Here are four stocks trading with relatively heavy volume among 49 equities making new 52-week lows in Friday's session. On the NYSE, decliners led advancers by more ...
Read Full Story »